+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

India Oncology Market 2023-2027

  • PDF Icon

    Report

  • 139 Pages
  • April 2023
  • Region: India
  • TechNavio
  • ID: 5513586
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The oncology market in India is forecast to grow by USD 947.84 mn during 2022-2027, accelerating at a CAGR of 13.45% during the forecast period. The report on the oncology market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increased prevalence of cancer, the need for cost-cutting in drug discovery and development, and the increasing demand for precision medicine.

The oncology market is segmented as below:

By Type

  • Cancer treatment
  • Cancer diagnostics

By End-user

  • Hospitals
  • Diagnostic laboratories
  • Diagnostic imaging centers
  • Others
This study identifies the rise in R and D as one of the prime reasons driving the oncology market growth during the next few years. Also, the rising adoption of immunotherapy and the rising adoption of robotic surgeries will lead to sizable demand in the market.

The report on the oncology market covers the following areas:

  • Oncology market sizing
  • Oncology market forecast
  • Oncology market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oncology market vendors that include 3M Co., Abbott Laboratories, Alkem Laboratories Ltd., AstraZeneca Plc, Baxter International Inc., Bristol Myers Squibb Co., Cipla Ltd., F. Hoffmann La Roche Ltd., GE Healthcare Technologies Inc., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Medtronic Plc, Merck and Co. Inc., NATCO Pharma Ltd., Novartis AG, Poly Medicure Ltd., Siemens Healthineers AG, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Lifesciences Ltd. Also, the oncology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market Segmentation by Type
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 07: Parent market
Exhibit 08: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 09: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 10: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 11: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 12: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 13: Chart on India: Year-over-year growth 2022-2027 (%)
Exhibit 14: Data Table on India: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Oncology market in India 2017 - 2021
Exhibit 15: Historic Market Size - Data Table on Oncology market in India 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 16: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 End user Segment Analysis 2017 - 2021
Exhibit 17: Historic Market Size - End user Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 21: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 22: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 23: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 25: Chart on Type - Market share 2022-2027 (%)
Exhibit 26: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 27: Chart on Comparison by Type
Exhibit 28: Data Table on Comparison by Type
6.3 Cancer treatment - Market size and forecast 2022-2027
Exhibit 29: Chart on Cancer treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 30: Data Table on Cancer treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 31: Chart on Cancer treatment - Year-over-year growth 2022-2027 (%)
Exhibit 32: Data Table on Cancer treatment - Year-over-year growth 2022-2027 (%)
6.4 Cancer diagnostics - Market size and forecast 2022-2027
Exhibit 33: Chart on Cancer diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 34: Data Table on Cancer diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Chart on Cancer diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 36: Data Table on Cancer diagnostics - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 37: Market opportunity by Type ($ million)
Exhibit 38: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 39: Chart on End-user - Market share 2022-2027 (%)
Exhibit 40: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 41: Chart on Comparison by End-user
Exhibit 42: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2022-2027
Exhibit 43: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 45: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 46: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.4 Diagnostic laboratories - Market size and forecast 2022-2027
Exhibit 47: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
7.5 Diagnostic imaging centers - Market size and forecast 2022-2027
Exhibit 51: Chart on Diagnostic imaging centers - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Diagnostic imaging centers - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Diagnostic imaging centers - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Diagnostic imaging centers - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by End-user
Exhibit 59: Market opportunity by End-user ($ million)
Exhibit 60: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 61: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Drivers, Challenges, and Trends
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Exhibit 62: Impact of drivers and challenges in 2022 and 2027
9.4 Market trends
10 Vendor Landscape
10.1 Overview
10.2 Vendor landscape
Exhibit 63: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
Exhibit 64: Overview on factors of disruption
10.4 Industry risks
Exhibit 65: Impact of key risks on business
11 Vendor Analysis
11.1 Vendors covered
Exhibit 66: Vendors covered
11.2 Market positioning of vendors
Exhibit 67: Matrix on vendor position and classification
11.3 Abbott Laboratories
Exhibit 68: Abbott Laboratories - Overview
Exhibit 69: Abbott Laboratories - Business segments
Exhibit 70: Abbott Laboratories - Key news
Exhibit 71: Abbott Laboratories - Key offerings
Exhibit 72: Abbott Laboratories - Segment focus
11.4 Alkem Laboratories Ltd.
Exhibit 73: Alkem Laboratories Ltd. - Overview
Exhibit 74: Alkem Laboratories Ltd. - Business segments
Exhibit 75: Alkem Laboratories Ltd. - Key news
Exhibit 76: Alkem Laboratories Ltd. - Key offerings
Exhibit 77: Alkem Laboratories Ltd. - Segment focus
11.5 AstraZeneca Plc
Exhibit 78: AstraZeneca Plc - Overview
Exhibit 79: AstraZeneca Plc - Product / Service
Exhibit 80: AstraZeneca Plc - Key news
Exhibit 81: AstraZeneca Plc - Key offerings
11.6 Bristol Myers Squibb Co.
Exhibit 82: Bristol Myers Squibb Co. - Overview
Exhibit 83: Bristol Myers Squibb Co. - Product / Service
Exhibit 84: Bristol Myers Squibb Co. - Key news
Exhibit 85: Bristol Myers Squibb Co. - Key offerings
11.7 Cipla Ltd.
Exhibit 86: Cipla Ltd. - Overview
Exhibit 87: Cipla Ltd. - Business segments
Exhibit 88: Cipla Ltd. - Key news
Exhibit 89: Cipla Ltd. - Key offerings
Exhibit 90: Cipla Ltd. - Segment focus
11.8 F. Hoffmann La Roche Ltd.
Exhibit 91: F. Hoffmann La Roche Ltd. - Overview
Exhibit 92: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 93: F. Hoffmann La Roche Ltd. - Key news
Exhibit 94: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 95: F. Hoffmann La Roche Ltd. - Segment focus
11.9 GE Healthcare Technologies Inc.
Exhibit 96: GE Healthcare Technologies Inc. - Overview
Exhibit 97: GE Healthcare Technologies Inc. - Business segments
Exhibit 98: GE Healthcare Technologies Inc. - Key offerings
Exhibit 99: GE Healthcare Technologies Inc. - Segment focus
11.10 Glenmark Pharmaceuticals Ltd.
Exhibit 100: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 101: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 102: Glenmark Pharmaceuticals Ltd. - Key offerings
11.11 Lupin Ltd.
Exhibit 103: Lupin Ltd. - Overview
Exhibit 104: Lupin Ltd. - Product / Service
Exhibit 105: Lupin Ltd. - Key news
Exhibit 106: Lupin Ltd. - Key offerings
11.12 Medtronic Plc
Exhibit 107: Medtronic Plc - Overview
Exhibit 108: Medtronic Plc - Business segments
Exhibit 109: Medtronic Plc - Key news
Exhibit 110: Medtronic Plc - Key offerings
Exhibit 111: Medtronic Plc - Segment focus
11.13 Merck and Co. Inc.
Exhibit 112: Merck and Co. Inc. - Overview
Exhibit 113: Merck and Co. Inc. - Business segments
Exhibit 114: Merck and Co. Inc. - Key news
Exhibit 115: Merck and Co. Inc. - Key offerings
Exhibit 116: Merck and Co. Inc. - Segment focus
11.14 NATCO Pharma Ltd.
Exhibit 117: NATCO Pharma Ltd. - Overview
Exhibit 118: NATCO Pharma Ltd. - Business segments
Exhibit 119: NATCO Pharma Ltd. - Key offerings
Exhibit 120: NATCO Pharma Ltd. - Segment focus
11.15 Siemens Healthineers AG
Exhibit 121: Siemens Healthineers AG - Overview
Exhibit 122: Siemens Healthineers AG - Business segments
Exhibit 123: Siemens Healthineers AG - Key news
Exhibit 124: Siemens Healthineers AG - Key offerings
Exhibit 125: Siemens Healthineers AG - Segment focus
11.16 Sun Pharmaceutical Industries Ltd.
Exhibit 126: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 127: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 128: Sun Pharmaceutical Industries Ltd. - Key offerings
11.17 Zydus Lifesciences Ltd.
Exhibit 129: Zydus Lifesciences Ltd. - Overview
Exhibit 130: Zydus Lifesciences Ltd. - Business segments
Exhibit 131: Zydus Lifesciences Ltd. - Key offerings
Exhibit 132: Zydus Lifesciences Ltd. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Exhibit 133: Inclusions checklist
Exhibit 134: Exclusions checklist
12.3 Currency conversion rates for US$
Exhibit 135: Currency conversion rates for US$
12.4 Research methodology
Exhibit 136: Research methodology
Exhibit 137: Validation techniques employed for market sizing
Exhibit 138: Information sources
12.5 List of abbreviations
Exhibit 139: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Type
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Vendor Market Positioning
Exhibits 7: Parent market
Exhibits 8: Market Characteristics
Exhibits 9: Offerings of vendors included in the market definition
Exhibits 10: Market segments
Exhibits 11: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits 12: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits 13: Chart on India: Year-over-year growth 2022-2027 (%)
Exhibits 14: Data Table on India: Year-over-year growth 2022-2027 (%)
Exhibits 15: Historic Market Size - Data Table on Oncology market in India 2017 - 2021 ($ million)
Exhibits 16: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 17: Historic Market Size - End user Segment 2017 - 2021 ($ million)
Exhibits 18: Five forces analysis - Comparison between 2022 and 2027
Exhibits 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 21: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 22: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 23: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 24: Chart on Market condition - Five forces 2022 and 2027
Exhibits 25: Chart on Type - Market share 2022-2027 (%)
Exhibits 26: Data Table on Type - Market share 2022-2027 (%)
Exhibits 27: Chart on Comparison by Type
Exhibits 28: Data Table on Comparison by Type
Exhibits 29: Chart on Cancer treatment - Market size and forecast 2022-2027 ($ million)
Exhibits 30: Data Table on Cancer treatment - Market size and forecast 2022-2027 ($ million)
Exhibits 31: Chart on Cancer treatment - Year-over-year growth 2022-2027 (%)
Exhibits 32: Data Table on Cancer treatment - Year-over-year growth 2022-2027 (%)
Exhibits 33: Chart on Cancer diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 34: Data Table on Cancer diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Chart on Cancer diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 36: Data Table on Cancer diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 37: Market opportunity by Type ($ million)
Exhibits 38: Data Table on Market opportunity by Type ($ million)
Exhibits 39: Chart on End-user - Market share 2022-2027 (%)
Exhibits 40: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 41: Chart on Comparison by End-user
Exhibits 42: Data Table on Comparison by End-user
Exhibits 43: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 45: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 46: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 47: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Diagnostic imaging centers - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Diagnostic imaging centers - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Diagnostic imaging centers - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Diagnostic imaging centers - Year-over-year growth 2022-2027 (%)
Exhibits 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 59: Market opportunity by End-user ($ million)
Exhibits 60: Data Table on Market opportunity by End-user ($ million)
Exhibits 61: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 62: Impact of drivers and challenges in 2022 and 2027
Exhibits 63: Overview on Criticality of inputs and Factors of differentiation
Exhibits 64: Overview on factors of disruption
Exhibits 65: Impact of key risks on business
Exhibits 66: Vendors covered
Exhibits 67: Matrix on vendor position and classification
Exhibits 68: Abbott Laboratories - Overview
Exhibits 69: Abbott Laboratories - Business segments
Exhibits 70: Abbott Laboratories - Key news
Exhibits 71: Abbott Laboratories - Key offerings
Exhibits 72: Abbott Laboratories - Segment focus
Exhibits 73: Alkem Laboratories Ltd. - Overview
Exhibits 74: Alkem Laboratories Ltd. - Business segments
Exhibits 75: Alkem Laboratories Ltd. - Key news
Exhibits 76: Alkem Laboratories Ltd. - Key offerings
Exhibits 77: Alkem Laboratories Ltd. - Segment focus
Exhibits 78: AstraZeneca Plc - Overview
Exhibits 79: AstraZeneca Plc - Product / Service
Exhibits 80: AstraZeneca Plc - Key news
Exhibits 81: AstraZeneca Plc - Key offerings
Exhibits 82: Bristol Myers Squibb Co. - Overview
Exhibits 83: Bristol Myers Squibb Co. - Product / Service
Exhibits 84: Bristol Myers Squibb Co. - Key news
Exhibits 85: Bristol Myers Squibb Co. - Key offerings
Exhibits 86: Cipla Ltd. - Overview
Exhibits 87: Cipla Ltd. - Business segments
Exhibits 88: Cipla Ltd. - Key news
Exhibits 89: Cipla Ltd. - Key offerings
Exhibits 90: Cipla Ltd. - Segment focus
Exhibits 91: F. Hoffmann La Roche Ltd. - Overview
Exhibits 92: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 93: F. Hoffmann La Roche Ltd. - Key news
Exhibits 94: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 95: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 96: GE Healthcare Technologies Inc. - Overview
Exhibits 97: GE Healthcare Technologies Inc. - Business segments
Exhibits 98: GE Healthcare Technologies Inc. - Key offerings
Exhibits 99: GE Healthcare Technologies Inc. - Segment focus
Exhibits 100: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 101: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits 102: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 103: Lupin Ltd. - Overview
Exhibits 104: Lupin Ltd. - Product / Service
Exhibits 105: Lupin Ltd. - Key news
Exhibits 106: Lupin Ltd. - Key offerings
Exhibits 107: Medtronic Plc - Overview
Exhibits 108: Medtronic Plc - Business segments
Exhibits 109: Medtronic Plc - Key news
Exhibits 110: Medtronic Plc - Key offerings
Exhibits 111: Medtronic Plc - Segment focus
Exhibits 112: Merck and Co. Inc. - Overview
Exhibits 113: Merck and Co. Inc. - Business segments
Exhibits 114: Merck and Co. Inc. - Key news
Exhibits 115: Merck and Co. Inc. - Key offerings
Exhibits 116: Merck and Co. Inc. - Segment focus
Exhibits 117: NATCO Pharma Ltd. - Overview
Exhibits 118: NATCO Pharma Ltd. - Business segments
Exhibits 119: NATCO Pharma Ltd. - Key offerings
Exhibits 120: NATCO Pharma Ltd. - Segment focus
Exhibits 121: Siemens Healthineers AG - Overview
Exhibits 122: Siemens Healthineers AG - Business segments
Exhibits 123: Siemens Healthineers AG - Key news
Exhibits 124: Siemens Healthineers AG - Key offerings
Exhibits 125: Siemens Healthineers AG - Segment focus
Exhibits 126: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 127: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 128: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 129: Zydus Lifesciences Ltd. - Overview
Exhibits 130: Zydus Lifesciences Ltd. - Business segments
Exhibits 131: Zydus Lifesciences Ltd. - Key offerings
Exhibits 132: Zydus Lifesciences Ltd. - Segment focus
Exhibits 133: Inclusions checklist
Exhibits 134: Exclusions checklist
Exhibits 135: Currency conversion rates for US$
Exhibits 136: Research methodology
Exhibits 137: Validation techniques employed for market sizing
Exhibits 138: Information sources
Exhibits 139: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global oncology market : 3M Co., Abbott Laboratories, Alkem Laboratories Ltd., AstraZeneca Plc, Baxter International Inc., Bristol Myers Squibb Co., Cipla Ltd., F. Hoffmann La Roche Ltd., GE Healthcare Technologies Inc., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Medtronic Plc, Merck and Co. Inc., NATCO Pharma Ltd., Novartis AG, Poly Medicure Ltd., Siemens Healthineers AG, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is a rise in R&D.`

According to the report, one of the major drivers for this market is the increased prevalence of cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3M Co.
  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • AstraZeneca Plc
  • Baxter International Inc.
  • Bristol Myers Squibb Co.
  • Cipla Ltd.
  • F. Hoffmann La Roche Ltd.
  • GE Healthcare Technologies Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Lupin Ltd.
  • Medtronic Plc
  • Merck and Co. Inc.
  • NATCO Pharma Ltd.
  • Novartis AG
  • Poly Medicure Ltd.
  • Siemens Healthineers AG
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Lifesciences Ltd.